Men and women with either impaired glucose tolerance or no identified glucose metabolism disorder had substantially lower 3-year mortality rates that ranged from 11% to 13%, Dr. Gitt added.
'Our new data confirm the recommendation' for oral glucose tolerance tests in acute MI patients.
Source DR. GITT